Product Description
Cartigenix HP® – Joint + Cartilage Support
Cartigenix HP is Clinically Shown to Support Cartilage Regeneration, Joint Flexibility and Comfort
These studies show†
- Cartigenix HP supports cartilage regeneration
- there was a significant increase in cartilage regeneration biomarkers in 90 days
- there was a significant decrease in cartilage degeneration biomarkers in 90 days
- Cartigenix HP reduces exercise-related stiffness and improves joint movement comfort, mobility
- there was a 67% average reduction in pain-stiffness score
- Cartigenix HP supports comfortable daily exercise
- there was a 50% average improvement in distance walked during 6 minute walk test
Participants reported noticeable improvements in as little as 15 days with taking Cartigenix HP.
†As shown in two placebo-controlled, randomized, controlled human research studies (Vaidya 2025; Desai 2024).
These studies examined the anti-inflammatory and analgesic properties of Celery seed and Boswellia serrata extracts as potential alternatives for osteoarthritis (OA) treatment, focusing on their effectiveness in reducing pain and improving joint functionality.
They also discussed the promising efficacy of celery seed and Boswellia serrata as a safer and effective adjunctive therapy for knee osteoarthritis, offering pain relief, enhanced joint functionality and potential reduction in NSAID (e.g. ibuprofen or aspirin) usage.
A prospective study (n=1,236) similarly demonstrated significant improvements in pain scores, along with quality of life measures (Desai 2022).
† These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Cartigenix HP Clinical Research Results:

†As shown in a placebo-controlled, randomized, controlled human research study (Vaidya 2025) and an observational study (Desai 2024). A prospective study (n=1,236) similarly demonstrated significant improvements in pain scores, along with quality of life measures (Desai 2022)
Cartigenix-HP Targets Structural Foundation of Joint Health
Backed by 3 published human trials, taking Cartigenix HP for 90 days.
Cartigenix uniquely contains a proprietary blend of Boswellia serrata and celery seed which has been demonstrated in studies to support joint health.
Cartigenix HP contains a proprietary clinically studied blend of 13 bioactive constituents (RestorCel™– including serratol from Boswellia serrata and compounds derived from a unique celery seed from Northern India. These compounds are complementary and work synergistically to support joint health.
Cartigenix HP is for:
- People who experience joint stiffness or discomfort
- Active adults seeking to maintain healthy movement and mobility
- Anyone wanting a clinically supported, proactive approach to joint and cartilage health
Manufactured in the US by Calroy Health Sciences (makers of Arterosil HP and Vascanox HP)















